SWOG clinical trial number
SWOG-9046
Evaluation of 10-EdAM in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Evaluation of 10-EdAM in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Activated
12/15/1990
Closed
04/01/1992
Publication Information Expand/Collapse
1994
Phase II study of edatrexate in advanced head and neck cancer: A Southwest Oncology Group study